Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8019)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 8, 2016 (publication date) through Nov 29, 2023
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tang LSY, Masur J, Sims Z, Nelson A, Osinusi A, Kohli A, Kattakuzhy S, Polis M, Kottilil S. Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment. World J Hepatol 2016; 8(31): 1318-1326 [PMID: 27872683 DOI: 10.4254/wjh.v8.i31.1318] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i31/1318.htm |
| Number | Citing Articles |
| 1 |
Luis Margusino‐Framiñán, Eva Bobadilla‐Pérez, Purificación Cid‐Silva, Alejandro Rodríguez‐Sotelo, Juan C. Yáñez‐Rubal, Álvaro Mena‐de‐Cea, Francisco Suárez‐López, Andrea Prieto‐Pérez, Víctor Giménez‐Arufe, Manuel Delgado‐Blanco, Ana I. Sanclaudio‐Luhia, Isabel Martín‐Herranz, Ángeles Castro‐Iglesias. Effectiveness and safety of direct‐acting antivirals in hepatitis C infected patients with mental disorders: Results in real clinical practice. Journal of Medical Virology 2020; 92(12): 3488 doi: 10.1002/jmv.25772
|
| 2 |
Luis Gutiérrez-Rojas, Jesús José de la Gándara Martín, Luisa García Buey, Juan I. Uriz Otano, Álvaro Mena, Carlos Roncero. Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review. Gastroenterología y Hepatología 2023; 46(5): 382 doi: 10.1016/j.gastrohep.2022.06.001
|
| 3 |
Isak Sundberg, Anders Lannergård, Mia Ramklint, Janet L. Cunningham. Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study. BMC Psychiatry 2018; 18(1) doi: 10.1186/s12888-018-1735-6
|
| 4 |
Matteo Tagliapietra, Salvatore Monaco. Neuroimaging Findings in Chronic Hepatitis C Virus Infection: Correlation with Neurocognitive and Neuropsychiatric Manifestations. International Journal of Molecular Sciences 2020; 21(7): 2478 doi: 10.3390/ijms21072478
|
| 5 |
Sern Wei Yeoh, Alex C. N. Holmes, Michael M. Saling, Ian P. Everall, Amanda J. Nicoll. Depression, fatigue and neurocognitive deficits in chronic hepatitis C. Hepatology International 2018; 12(4): 294 doi: 10.1007/s12072-018-9879-5
|
| 6 |
Silvia Nardelli, Oliviero Riggio, Davide Rosati, Stefania Gioia, Alessio Farcomeni, Lorenzo Ridola. Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms. World Journal of Gastroenterology 2019; 25(48): 6928-6938 doi: 10.3748/wjg.v25.i48.6928
|
| 7 |
Daphne Hahn, Caroline S. Stokes, Ralf Kaiser, Markus R. Meyer, Frank Lammert, Frank Gruenhage. Antidepressant effects of direct‐acting antivirals against hepatitis C virus—Results from a pilot study. European Journal of Clinical Investigation 2018; 48(12) doi: 10.1111/eci.13024
|
| 8 |
Marta Gallach, Mercedes Vergara, Joao Pedro da Costa, Mireia Miquel, Meritxell Casas, Jordi Sanchez-Delgado, Blai Dalmau, Núria Rudi, Isabel Parra, Teresa Monllor, Meritxell Sanchez-Lloansí, Angelina Dosal, Oliver Valero, Xavier Calvet, Jee-Fu Huang. Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C. PLOS ONE 2018; 13(12): e0208112 doi: 10.1371/journal.pone.0208112
|
| 9 |
Letitia E. Travaglini, Julie Kreyenbuhl, Meagan Graydon, Clayton H. Brown, Richard Goldberg, Seth Himelhoch, Li Juan Fang, Eric Slade. Access to Direct-Acting Antiviral Treatment for Hepatitis C Virus Among Veterans With Serious Mental Illness. Psychiatric Services 2020; 71(2): 192 doi: 10.1176/appi.ps.201900227
|
| 10 |
Riccardo Nevola, Luca Rinaldi, Letizia Zeni, Ciro Romano, Aldo Marrone, Raffaele Galiero, Pia Clara Pafundi, Carlo Acierno, Erica Vetrano, Luigi Elio Adinolfi. Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals. Expert Review of Gastroenterology & Hepatology 2021; 15(6): 643 doi: 10.1080/17474124.2021.1877136
|
| 11 |
Luis Gutiérrez-Rojas, Jesús José de la Gándara Martín, Luisa García Buey, Juan I. Uriz Otano, Álvaro Mena, Carlos Roncero. Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review. Gastroenterología y Hepatología (English Edition) 2023; 46(5): 382 doi: 10.1016/j.gastre.2022.06.009
|
| 12 |
Maria Janda, Kari A. Mergenhagen. The Effect of Psychosocial Factors on Success Rates of Hepatitis C Treatment. Psychosomatics 2017; 58(6): 624 doi: 10.1016/j.psym.2017.07.003
|
| 13 |
L V Brown, E A Gaffney, J Wagg, M C Coles. Applications of mechanistic modelling to clinical and experimental immunology: an emerging technology to accelerate immunotherapeutic discovery and development. Clinical and Experimental Immunology 2018; 193(3): 284 doi: 10.1111/cei.13182
|
| 14 |
Claudia Monica Danilescu, Daniela Larisa Sandulescu, Mihail Cristian Pirlog, Costin Teodor Streba, Ion Rogoveanu. Depressive and Anxious Symptoms in Hepatitis C Virus Infected Patients Receiving DAA-Based Therapy. Diagnostics 2021; 11(12): 2237 doi: 10.3390/diagnostics11122237
|
| 15 |
Irene Pericot-Valverde, Moonseong Heo, Jiajing Niu, Lior Rennert, Brianna L. Norton, Matthew J. Akiyama, Julia Arnsten, Alain H. Litwin. Relationship between depressive symptoms and adherence to direct-acting antivirals: Implications for Hepatitis C treatment among people who inject drugs on medications for opioid use disorder. Drug and Alcohol Dependence 2022; 234: 109403 doi: 10.1016/j.drugalcdep.2022.109403
|
| 16 |
Irene Pericot-Valverde, Moonseong Heo, Jiajing Niu, Brianna L Norton, Matthew J Akiyama, Linda Agyemang, Alain H Litwin. Declines in Depressive Symptoms Among People who Inject Drugs Treated With Direct-Acting Antivirals While on Opioid Agonist Therapy. Open Forum Infectious Diseases 2020; 7(10) doi: 10.1093/ofid/ofaa380
|
| 17 |
Xiaoping He, Lynne Hopkins, George Everett, Willie M Carter, Cynthia SchroppDyce, Khalid Abusaada, Vincent Hsu. Safety and efficacy of ledipasvir/sofosbuvir on hepatitis C eradication in hepatitis C virus/human immunodeficiency virus co-infected patients. World Journal of Hepatology 2017; 9(30): 1190-1196 doi: 10.4254/wjh.v9.i30.1190
|
| 18 |
David Back, Pamela Belperio, Mark Bondin, Francesco Negro, Andrew H. Talal, Caroline Park, ZhenZhen Zhang, Brett Pinsky, Eric Crown, Federico J. Mensa, Fiona Marra. Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: An integrated analysis. Journal of Viral Hepatitis 2019; 26(8): 951 doi: 10.1111/jvh.13110
|
| 19 |
Kosuke Takeda, Ryuichi Noguchi, Tadashi Namisaki, Kei Moriya, Takemi Akahane, Mitsuteru Kitade, Hideto Kawaratani, Naotaka Shimozato, Kosuke Kaji, Hiroaki Takaya, Yasuhiko Sawada, Kenichiro Seki, Yukihisa Fujinaga, Yuki Tsuji, Takuya Kubo, Shinya Sato, Soichiro Saikawa, Keisuke Nakanishi, Masanori Furukawa, Koh Kitagawa, Takahiro Ozutsumi, Daisuke Kaya, Akira Mitoro, Tsuyoshi Mashitani, Yasushi Okura, Junichi Yamao, Hitoshi Yoshiji. Efficacy and tolerability of interferon‑free regimen for patients with genotype‑1 HCV infection. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6481
|